Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.848 EUR | -0.35% | -1.40% | +6.53% |
Business Summary
Number of employees: 307
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drug
92.7
%
| 41 | 88.6 % | 47 | 92.7 % | +15.80% |
Parapharmaceutical
4.4
%
| 4 | 7.8 % | 2 | 4.4 % | -37.98% |
Services
3.0
%
| 2 | 3.6 % | 2 | 3.0 % | -9.01% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Greece
48.4
%
| 31 | 67.8 % | 25 | 48.4 % | -21.00% |
European Union
44.7
%
| 12 | 26.5 % | 23 | 44.7 % | +86.44% |
Other Countries
7.0
%
| 3 | 5.7 % | 4 | 7.0 % | +35.18% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | - | 30/11/21 | |
Compliance Officer | - | - | |
Chief Operating Officer | - | - | |
Director/Board Member | - | 31/12/02 | |
Theodora Chavela
LAW | General Counsel | - | 31/12/17 |
Xenofon Economou
AUD | Comptroller/Controller/Auditor | - | 30/04/19 |
Mariza Antonaki
HRO | Human Resources Officer | - | 31/12/21 |
Sales & Marketing | - | 31/12/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | - | |
Minas G. Tanes
CHM | Chairman | 84 | 31/12/08 |
Director/Board Member | - | 31/12/02 | |
Director/Board Member | - | - | |
Director/Board Member | - | - | |
Director/Board Member | 74 | - | |
Vicky Kefalas
BRD | Director/Board Member | - | 25/05/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 167,868,482 | 64,041,826 ( 38.15 %) | 0 | 38.15 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+6.53% | 153M | |
+19.98% | 43.48B | |
+20.67% | 22.65B | |
+14.56% | 14.73B | |
+14.32% | 13.79B | |
+44.72% | 12.04B | |
-8.37% | 7.08B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.90% | 5.47B |
- Stock Market
- Equities
- LAVI Stock
- Company Lavipharm S.A.